Purchase Order SPE2DP24V2514
Award Date
9/3/24
Potential Completion Date
9/18/24
Potential Value
$1K
Federal Agency
Medical Supply Chain
Awardee
The Maclean Group LLC
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sacramento, CA 95825, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded numerous prime federal...
The U.S. Department of Defense's Medical Supply Chain agency has awarded a firm fixed-price purchase order contract valued at $1,005.03 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has an ultimate completion date of May 10, 2024. The Maclean Group is an ISO 9001:2015 certified medical and...
This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510696704 - Naloxone Hydrochloride, a critical drug used to treat opioid overdose. The award has a completion date of June 18, 2024 and is structured as a firm fixed price purchase order. The Maclean Group LLC is an ISO...
This is a firm fixed price purchase order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract, valued at $2,010.06, is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has a performance period ending on May 10, 2024. The Maclean Group is an ISO 9001:2015 certified...
This federal contract award, valued at $1,005.03, was issued by the Defense agency Medical Supply Chain to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510987189 - Naloxone Hydrochloride, a medication used to reverse opioid overdose. The Maclean Group LLC has secured this firm-fixed price purchase order with an ultimate completion date of November 13, 2024. The company has established...
This federal contract award, valued at $1,005.03, was issued by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, and has an ultimate completion date of October 3, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been...
The U.S. government's Defense agency, specifically the Medical Supply Chain, has awarded a $4,020.12 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose, with a completion date of June 18, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale...
This federal contract awarded by the Defense agency's Medical Supply Chain organization is for the purchase of 8510647644 units of Naloxone Hydrochloride, a critical medication used to reverse opioid overdose. The $2,010.06 firm fixed price contract was awarded to The Maclean Group LLC, a small disadvantaged, veteran-owned business that provides medical and pharmaceutical distribution services to various government agencies. The Maclean Group holds several significant federal supply schedule and...
The U.S. Defense Logistics Agency (DLA) awarded a $2,010.06 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride, a medication used to reverse opioid overdose. This contract has an ultimate completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several...
The U.S. Department of Defense's Medical Supply Chain agency awarded a $2,010.06 firm-fixed-price purchase order to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the delivery of naloxone hydrochloride. This contract, awarded on October 1, 2024 with an ultimate completion date of October 16, 2024, is not designated as a set-aside. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale...